Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice

Abstract Background Idiopathic pulmonary fibrosis is characterized by loss of lung epithelial cells and inexorable progression of fibrosis with no effective and approved treatments. The distal airway stem/progenitor cells (DASCs) have been shown to have potent regenerative capacity after lung injury...

Full description

Bibliographic Details
Main Authors: Yun Shi, Mingqing Dong, Yueqing Zhou, Wangping Li, Yongheng Gao, Luyao Han, Min Chen, Hongwei Lin, Wei Zuo, Faguang Jin
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13287-019-1257-2
_version_ 1819073310529421312
author Yun Shi
Mingqing Dong
Yueqing Zhou
Wangping Li
Yongheng Gao
Luyao Han
Min Chen
Hongwei Lin
Wei Zuo
Faguang Jin
author_facet Yun Shi
Mingqing Dong
Yueqing Zhou
Wangping Li
Yongheng Gao
Luyao Han
Min Chen
Hongwei Lin
Wei Zuo
Faguang Jin
author_sort Yun Shi
collection DOAJ
description Abstract Background Idiopathic pulmonary fibrosis is characterized by loss of lung epithelial cells and inexorable progression of fibrosis with no effective and approved treatments. The distal airway stem/progenitor cells (DASCs) have been shown to have potent regenerative capacity after lung injury. In this work, we aimed to define the role of mouse DASCs (mDASCs) in response to bleomycin-induced lung fibrosis in mice. Methods The mDASCs were isolated, expanded in vitro, and labeled with GFP by lentiviral infection. The labeled mDASCs were intratracheally instilled into bleomycin-induced pulmonary fibrosis mice on day 7. Pathological change, collagen content, α-SMA expression, lung function, and mortality rate were assessed at 7, 14, and 21 days after bleomycin administration. Tissue section and direct fluorescence staining was used to show the distribution and differentiation of mDASCs in lung. Results The transplanted mDASCs could incorporate, proliferate, and differentiate into type I pneumocytes in bleomycin-injured lung. They also inhibited fibrogenesis by attenuating the deposition of collagen and expression of α-SMA. In addition, mDASCs improved pulmonary function and reduce mortality in bleomycin-induced pulmonary fibrosis mice. Conclusions The data strongly suggest that mDASCs could ameliorate bleomycin-induced pulmonary fibrosis by promotion of lung regeneration and inhibition of lung fibrogenesis.
first_indexed 2024-12-21T17:51:35Z
format Article
id doaj.art-2bdde017cf864db8949a9a292cb239a7
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-12-21T17:51:35Z
publishDate 2019-06-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-2bdde017cf864db8949a9a292cb239a72022-12-21T18:55:19ZengBMCStem Cell Research & Therapy1757-65122019-06-0110111110.1186/s13287-019-1257-2Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in miceYun Shi0Mingqing Dong1Yueqing Zhou2Wangping Li3Yongheng Gao4Luyao Han5Min Chen6Hongwei Lin7Wei Zuo8Faguang Jin9Department of Respiratory and Critical Care Medicine, Tangdu Hospital, Fourth Military Medical UniversityXi’an International UniversityShanghai East Hospital, School of Medicine, Tongji UniversityDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Fourth Military Medical UniversityDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Fourth Military Medical UniversityDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Fourth Military Medical UniversityDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Fourth Military Medical UniversityDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Fourth Military Medical UniversityShanghai East Hospital, School of Medicine, Tongji UniversityDepartment of Respiratory and Critical Care Medicine, Tangdu Hospital, Fourth Military Medical UniversityAbstract Background Idiopathic pulmonary fibrosis is characterized by loss of lung epithelial cells and inexorable progression of fibrosis with no effective and approved treatments. The distal airway stem/progenitor cells (DASCs) have been shown to have potent regenerative capacity after lung injury. In this work, we aimed to define the role of mouse DASCs (mDASCs) in response to bleomycin-induced lung fibrosis in mice. Methods The mDASCs were isolated, expanded in vitro, and labeled with GFP by lentiviral infection. The labeled mDASCs were intratracheally instilled into bleomycin-induced pulmonary fibrosis mice on day 7. Pathological change, collagen content, α-SMA expression, lung function, and mortality rate were assessed at 7, 14, and 21 days after bleomycin administration. Tissue section and direct fluorescence staining was used to show the distribution and differentiation of mDASCs in lung. Results The transplanted mDASCs could incorporate, proliferate, and differentiate into type I pneumocytes in bleomycin-injured lung. They also inhibited fibrogenesis by attenuating the deposition of collagen and expression of α-SMA. In addition, mDASCs improved pulmonary function and reduce mortality in bleomycin-induced pulmonary fibrosis mice. Conclusions The data strongly suggest that mDASCs could ameliorate bleomycin-induced pulmonary fibrosis by promotion of lung regeneration and inhibition of lung fibrogenesis.http://link.springer.com/article/10.1186/s13287-019-1257-2Pulmonary fibrosisDistal airway stem/progenitor cellsBleomycin
spellingShingle Yun Shi
Mingqing Dong
Yueqing Zhou
Wangping Li
Yongheng Gao
Luyao Han
Min Chen
Hongwei Lin
Wei Zuo
Faguang Jin
Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice
Stem Cell Research & Therapy
Pulmonary fibrosis
Distal airway stem/progenitor cells
Bleomycin
title Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice
title_full Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice
title_fullStr Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice
title_full_unstemmed Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice
title_short Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice
title_sort distal airway stem cells ameliorate bleomycin induced pulmonary fibrosis in mice
topic Pulmonary fibrosis
Distal airway stem/progenitor cells
Bleomycin
url http://link.springer.com/article/10.1186/s13287-019-1257-2
work_keys_str_mv AT yunshi distalairwaystemcellsamelioratebleomycininducedpulmonaryfibrosisinmice
AT mingqingdong distalairwaystemcellsamelioratebleomycininducedpulmonaryfibrosisinmice
AT yueqingzhou distalairwaystemcellsamelioratebleomycininducedpulmonaryfibrosisinmice
AT wangpingli distalairwaystemcellsamelioratebleomycininducedpulmonaryfibrosisinmice
AT yonghenggao distalairwaystemcellsamelioratebleomycininducedpulmonaryfibrosisinmice
AT luyaohan distalairwaystemcellsamelioratebleomycininducedpulmonaryfibrosisinmice
AT minchen distalairwaystemcellsamelioratebleomycininducedpulmonaryfibrosisinmice
AT hongweilin distalairwaystemcellsamelioratebleomycininducedpulmonaryfibrosisinmice
AT weizuo distalairwaystemcellsamelioratebleomycininducedpulmonaryfibrosisinmice
AT faguangjin distalairwaystemcellsamelioratebleomycininducedpulmonaryfibrosisinmice